Search clinical trials for: PDL-1 positive

Total 57403 results

Tobira Therapeutics, Inc.

Completed

Efficacy, Safety, and Tolerability of Cenicriviroc (CVC) in Combination With Truvada or Sustiva Plus Truvada in HIV 1-infected, Antiretroviral Treatment-naïve, Adult Patients Infected With Only CCR5-tropic Virus

HIV-1 Infection

United States, Puerto Rico
Newcastle-upon-Tyne Hospitals NHS Trust

Recruiting

Global Registry for COL6-related Dystrophies

Bethlem Myopathy | Ullrich Congenital Muscular Dystrophy 1, Digenic, Col6A1/Col6A2 | Ullrich Congenital Muscular Dystrophy 1, Autosomal Recessive | Ullrich Congenital Muscular Dystrophy 1, Autosomal Dominant | Bethlem Myopathy 1, Autosomal Recessive | UCMD | BTHLM1

United Kingdom
National Cancer Institute (NCI)

Completed

Bortezomib and Lenalidomide in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma

Recurrent Mantle Cell Lymphoma

United States
Haruhiko Fukuda
Ministry of Health, Labour and Welfare, Japan

Completed

A Phase II Study of Stereotactic Body Radiation Therapy in Patients With T1N0M0 Non-small Cell Lung Cancer (JCOG0403)

T1N0M0 Non-small Cell Lung Cancer

Japan
Eli Lilly and Company

Active, not recruiting

A Study of LY3484356 in Chinese Participants With Advanced Breast Cancer

Breast Neoplasms

China
Eli Lilly and Company

Active, not recruiting

A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer) (CYCLONE 3)

Urogenital Neoplasms | Prostatic Neoplasms | Neoplasm Metastasis | Enzyme Inhibitors | Antineoplastic Agents | Hormones | Physiological Effects of Drugs | Antineoplastic Agents, Hormonal | Androgens | Hormones, Hormone Substitutes, and Hormone Antagonists | Abiraterone Acetate | Steroid Synthesis Inhibitors | Cytochrome... and other conditions

China, Canada, France, United States, Australia, Czechia, Hungary, Spain, Germany, Japan, Taiwan, Netherlands, Turkey, Mexico, Belgium, Korea, Republic of, Argentina, Romania, United Kingdom, Italy, Israel, Brazil, Poland, Greece
Eli Lilly and Company

Active, not recruiting

A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma

Relapsed Solid Tumor | Refractory Solid Tumor

United States, France, Australia, Belgium, Germany, Japan, Spain, Italy
Eli Lilly and Company
Incyte Corporation

Active, not recruiting

A Study of Baricitinib (LY3009104) in Participants With Severe or Very Severe Alopecia Areata (BRAVE-AA1)

Alopecia Areata

United States, Japan, Puerto Rico, Mexico, Korea, Republic of
Eli Lilly and Company

Terminated

A Study of LY3844583 in Healthy Participants and Participants With Atopic Dermatitis

Healthy | Dermatitis, Atopic

Japan, United States
Eli Lilly and Company

Active, not recruiting

A Study of LY3541105 in Healthy and Overweight Participants

Healthy | Overweight

United States
Eli Lilly and Company

Active, not recruiting

A Study to Evaluate Tirzepatide (LY3298176) in Pediatric and Adolescent Participants With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin or Basal Insulin or Both (SURPASS-PEDS)

Glucose Metabolism Disorders | Diabetes Mellitus, Type 2 | Diabetes Mellitus | Endocrine System Diseases | Type2 Diabetes | Metabolic Disease | T2DM (Type 2 Diabetes Mellitus) | T2D

United States, India, Australia, United Kingdom, Mexico, Brazil, Israel, France, Italy
Eli Lilly and Company

Completed

A Study of LY3848575 in Healthy Participants

Healthy

United States
Eli Lilly and Company

Active, not recruiting

A Study of LY3437943 in Healthy Participants With a High Body Mass Index

Healthy

United States
Eli Lilly and Company

Active, not recruiting

A Study of Ixekizumab (LY2439821) in Children With Juvenile Idiopathic Arthritis Categories of Enthesitis-related Arthritis (Including Juvenile Onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritis

Juvenile Psoriatic Arthritis | Enthesitis Related Arthritis

Spain, Belgium, Germany, Italy, United Kingdom, Denmark, Mexico, Netherlands, Switzerland
Eli Lilly and Company

Completed

A Study of Insulin Efsitora Alfa (LY3209590) as a Weekly Basal Insulin Compared to Insulin Glargine in Adult Participants With Type 2 Diabetes on Multiple Daily Injections (QWINT-4)

Type 2 Diabetes | Type 2 Diabetes Treated With Insulin

United States, Germany, Mexico, Argentina, Puerto Rico, Italy, Spain, India
Eli Lilly and Company

Completed

A IMMA Master Protocol: A Study of LY3361237 in Participants With at Least Moderately Active Systemic Lupus Erythematosus

Systemic Lupus Erythematosus

United States, Puerto Rico, Czechia, Taiwan, Argentina, France, Poland, Mexico
Eli Lilly and Company

Completed

A Relative Bioavailability Study of Peresolimab (LY3462817) Formulations in Healthy Participants

Healthy

United States
Eli Lilly and Company

Completed

A Study of LY3457263 Alone and in Combination With Dulaglutide (LY2189265) in Participants With Type 2 Diabetes

Diabetes Mellitus, Type 2

United States
Eli Lilly and Company

Completed

A Chronic Pain Master Protocol (CPMP): A Study of LY3857210 in Participants With Diabetic Peripheral Neuropathic Pain (NP05)

Chronic Pain | Diabetic Peripheral Neuropathic Pain | Diabetic Peripheral Neuropathy

United States, Puerto Rico
Hospital for Special Surgery, New York

Recruiting

Gastric Ultrasound Assessment for Patients Taking GLP1 Agonists

Glucagon-like Peptide 1 | Gastric Ultrasound | Point of Care Ultrasound

United States, Canada
University of Pennsylvania

Completed

Sexual and Gender Minority Emerging Adults Eliciting Narratives (SEEN)

Mental Health Wellness 1 | Gender Identity | Sexual Orientation

United States
Vakif Gureba Training and Research Hospital

Completed

Cross-Education Of Contralateral Antagonists

Muscle Strength Quantitative Trait Locus 1
Centre Jean Perrin
Université d'Auvergne; Institut National de Recherche pour l'Agriculture, l... and other collaborators

Recruiting

Microbiota and the Lung Cancer (MICA)

Non Small Cell Lung Cancer

France
Centre Hospitalier Universitaire de Nice

Completed

Dental Care and Initiation of Anti-osteoporotic Therapy

Osteoporosis | Dental Condition

France
B.P. Koirala Institute of Health Sciences

Completed

Laparoscopy in Complicated Groin Hernia

Inguinal Hernia

Nepal
B.P. Koirala Institute of Health Sciences

Completed

Operative Difficulty Grading Scale for Laparoscopic Cholecystectomy in BPKIHS

Laparoscopic Cholecystectomy

Nepal
B.P. Koirala Institute of Health Sciences
University Grants Commission

Completed

Efficacy of Pregabalin for the Treatment of Acute Herpetic Neuralgia

Herpes Zoster

Nepal
B.P. Koirala Institute of Health Sciences

Unknown

A Comparative Study of Airtraq Versus Macintosh Laryngoscope for Endotracheal Intubation by First Year Resident

Intubation Complication | Intubation; Difficult or Failed

Nepal
Immunomolecular Therapeutics, Inc.
WCCT Global

Completed

Multiple Ascending Dose (MAD) Study of IMT-002 in HLA-DQ8-positive Type 1 Diabetes

Type1 Diabetes

United States
Apokus AS
Norwegian Pharmacy Association

Completed

Effectiveness of "Medisinstart"

Cardiovascular Diseases

Norway
Abbott Diabetes Care

Recruiting

Effect on HbA1c of the Initiation of CGM in Adults With Type 2 Diabetes Treated With Basal Insulin in Finland

Type 2 Diabetes Treated With Insulin

Finland
University of Florence

Completed

Oral Contraceptive Therapy and Sexuality (COSEX)

Mental Health Wellness 1 | Sexual Behavior | Contraceptive Usage

Italy
Pfizer

Terminated

A Phase 2B Multicenter, Randomized, Comparative Trial Of UK-453,061 Versus Etravirine In Combination With Darunavir/Ritonavir And A Nucleos(t)Ide Reverse Transcriptase Inhibitor For The Treatment Of Antiretroviral Experienced HIV-1 Infected Subjects With Evidence Of NNRTI Resistant HIV-1

HIV-1

Spain, United Kingdom, Malaysia, United States, Portugal, Brazil, Germany, Italy, Poland, Puerto Rico, South Africa, Taiwan, Ukraine
University of Oxford
Medical Research Council

Terminated

Safety and Immunogenicity of MVA.HIVconsv in HIV-1 Seropositive Adults on HAART

HIV-1

United Kingdom
Christoph Stephan
University Hospital Heidelberg

Completed

Impact of Raltegravir on HIV-1 cDNA Slope Following Antiretroviral Therapy (ART) Initiation

HIV-1

Germany
ViiV Healthcare
Pfizer

Terminated

Comparative Trial Of Maraviroc Versus Emtricitabine/Tenofovir Both With Darunavir/Ritonavir In Antiretroviral-Naive Patients Infected With CCR5 Tropic HIV 1 (MODERN)

HIV-1

United States, Netherlands, Spain, Puerto Rico, Canada, Australia, Germany, Sweden, Poland, Portugal, Switzerland, France, Denmark, Italy, Belgium, United Kingdom, Hungary, Austria, Finland
Tibotec Pharmaceuticals, Ireland

Completed

The TMC125-C214 Study Provides Early Access to TMC125 for HIV-1 Infected Patients Who Have Failed Multiple Antiretroviral Regimens and Will Also Gather Information on the Long-term Safety and Tolerability of TMC125 Combined With Other Antiretroviral Drugs

HIV-1

United States, Belgium, Germany, Taiwan, Spain, Mexico, Turkey, Canada, Netherlands, Denmark, Greece, Sweden, Korea, Republic of, Russian Federation, Puerto Rico, Luxembourg
Juan A. Arnaiz

Completed

Metabolic Effects of Atazanavir/Ritonavir Versus Darunavir/Ritonavir in Combination With Tenofovir/Emtricitabine in naïve HIV-1 Infected Patients

HIV-1

Spain
GlaxoSmithKline

Terminated

Open Label Study of 908/RTV in Combination With Other PIs for the Treatment of Multi PI-Experienced HIV Subjects

HIV-1

Australia, Belgium, Canada, France, Germany, Greece, Italy, Spain, United Kingdom
Duke University
University of Pittsburgh; University of South Carolina; Whole Child International

Completed

National Evaluation of Quality of Childcare (ENCCI)

Mental Health Wellness 1 | Health Behavior | Child Rearing

El Salvador
Azienda Sanitaria Locale CN2 Alba-Bra
University of Turin, Italy; University of Eastern Piedmont; Eclectica Sas di...

Completed

Effectiveness of the Updated Version of the School-based Program Diario Della Salute (DDS-2) (DDS-2)

Mental Health Wellness 1 | Health Behavior | Adolescent Behavior

Italy
Wang Yongtai Raymond
The N.1 Institute for Health (N.1)

Not yet recruiting

Effects of Different Cardiorespiratory Training Program on Endurance Performance

Healthy

Singapore
Eli Lilly and Company

Completed

A Study of LY2875358 in Participants With MET Positive, Advanced Gastric Cancer

Gastric Cancer

Japan, Korea, Republic of
Eli Lilly and Company

Recruiting

A Drug-Drug Interaction (DDI) Study of Orforglipron With Carbamazepine in Healthy Participants

Healthy

United States
Eli Lilly and Company

Recruiting

A Study of LY3938577 in Healthy Participants and Participants With Type 1 Diabetes Mellitus (T1DM)

Healthy | Type 1 Diabetes Mellitus

Germany
Eli Lilly and Company

Active, not recruiting

A Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Participants With ER+, HER2- Advanced Breast Cancer (EMBER-3)

Breast Neoplasms | Neoplasm Metastasis

United States, Spain, China, Germany, France, Australia, Taiwan, Japan, India, Turkey, Belgium, Argentina, Austria, Italy, Mexico, Korea, Republic of, Greece, Netherlands, Brazil, Ukraine, Russian Federation, Czechia
Eli Lilly and Company

Completed

A Study of LY3461767 in Participants With Chronic Heart Failure With Reduced Ejection Fraction

Chronic Heart Failure With Reduced Ejection Fraction

United States, Japan
Eli Lilly and Company

Active, not recruiting

A Study of (LY3650150) Lebrikizumab to Assess the Safety and Efficacy of Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis and Skin of Color (ADmirable)

Atopic Dermatitis

United States
Eli Lilly and Company

Completed

A Study of LY3841136 in Healthy and Overweight Participants

Healthy | Obesity

United States
Eli Lilly and Company

Completed

A Study of Imlunestrant (LY3484356) in Female Participants With Impaired Liver Function

Hepatic Insufficiency | Healthy

United States

Search clinical trials for: PDL-1 positive

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Brazil

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations